Medika Natura Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Medika Natura General Information

Description

Operator of a biopharmaceutical therapeutics company intended to provide botanical drugs. The company specializes in the development, production, and commercialization of botanical bio-active compounds for the treatment of obesity, diabetes, cancer, and COVID-19, helping patients tackle metabolic syndrome diseases.

Contact Information

Formerly Known As
Orchid Life
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 44B, Jalan Bola Tampar, 13/14
  • Seksyen 13
  • Shah Alam, Selangor
  • Malaysia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 44B, Jalan Bola Tampar, 13/14
  • Seksyen 13
  • Shah Alam, Selangor
  • Malaysia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medika Natura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Dec-2022 Completed Generating Revenue
2. Seed Round 19-Feb-2020 Completed Generating Revenue
1. Seed Round 01-Jan-2008 Completed Generating Revenue
To view Medika Natura’s complete valuation and funding history, request access »

Medika Natura Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Medika Natura’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Medika Natura Patents

Medika Natura Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4426326-A1 Labisia pumila extract composition and its pharmaceutical formulation Pending 02-Nov-2021
US-12403166-B2 Labisia pumila extract composition and its pharmaceutical formulation Active 02-Nov-2021
US-20230134529-A1 Labisia pumila extract composition and its pharmaceutical formulation Active 02-Nov-2021
US-20250288629-A1 Labisia pumila extract composition and its pharmaceutical formulation Pending 02-Nov-2021
WO-2023080772-A1 Labisia pumila extract composition and its pharmaceutical formulation Inactive 02-Nov-2021 A61K36/185
To view Medika Natura’s complete patent history, request access »

Medika Natura Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cradle Fund Accelerator/Incubator Minority
Malaysian Technology Development Corporation Venture Capital Minority
RIO Ventures Holdings Venture Capital Minority
Malaysian Bioeconomy Development Corporation Other Minority
To view Medika Natura’s complete investors history, request access »

Medika Natura FAQs

  • When was Medika Natura founded?

    Medika Natura was founded in 2006.

  • Where is Medika Natura headquartered?

    Medika Natura is headquartered in Shah Alam, Malaysia.

  • What industry is Medika Natura in?

    Medika Natura’s primary industry is Drug Discovery.

  • Is Medika Natura a private or public company?

    Medika Natura is a Private company.

  • What is Medika Natura’s current revenue?

    The current revenue for Medika Natura is .

  • How much funding has Medika Natura raised over time?

    Medika Natura has raised $26.5K.

  • Who are Medika Natura’s investors?

    Cradle Fund, Malaysian Technology Development Corporation, RIO Ventures Holdings, and Malaysian Bioeconomy Development Corporation have invested in Medika Natura.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process